Literature DB >> 15174520

Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging.

Christopher M McPherson1, Ronald E Warnick.   

Abstract

OBJECTIVE: Radiation necrosis is a well-known complication of radiotherapy for malignant brain tumors. Although surgery was once considered the mainstay of treatment, no recent reports have evaluated the use of intraoperative magnetic resonance imaging (IOMRI) and frameless stereotaxis during surgical resection of radiation necrosis. In this retrospective review, we evaluate the effectiveness of surgical resection using frameless stereotaxis and IOMRI for the treatment of radiation necrosis.
METHODS: From October 1999 through February 2002, 11 patients who had malignant brain tumors underwent surgery for radiation necrosis. The diagnosis of radiation necrosis was based primarily on MRI and clinical suspicion. Frameless stereotaxis was used in all patients and IOMRI was used in nine. All patients underwent at least one radiation treatment before surgery and nine patients had multiple treatments. Patient outcome was based on changes in steroid dose, Karnofsky Performance Score (KPS), and neurologic deficit.
RESULTS: Optimal resection as confirmed by IOMRI was achieved in all patients by the use of frameless stereotaxis alone; no additional resection was performed in any patient. For nine patients taking steroids (mean preoperative dose 24 mg/day) before treatment of necrosis, all had a substantial reduction in steroid dosage (mean postoperative dose 8 mg/day) after surgical treatment. Postoperatively, KPS improved in four patients, remained stable in four, and worsened in three. Three complications that resulted from surgery included wound infection, asymptomatic carotid dissection, and pulmonary embolism; thus, overall morbidity including both surgical complications and neurologic deterioration was 54%.
CONCLUSIONS: In this review, frameless stereotaxis was helpful in guiding the surgeon; however, IOMRI did not provide any additional benefit for the surgical treatment of radiation necrosis. Surgical treatment of radiation necrosis was associated with high risks of complication or neurologic deficit. Given the success of medical therapies, including hyperbaric oxygen, we believe that surgical treatment of radiation necrosis should be reserved for symptomatic patients in whom medical therapy has failed.

Entities:  

Mesh:

Year:  2004        PMID: 15174520     DOI: 10.1023/b:neon.0000024744.16031.e9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  Radiation damage to the brain--a new syndrome.

Authors:  W D RIDER
Journal:  J Can Assoc Radiol       Date:  1963-06

2.  Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up.

Authors:  L S Chin; L Ma; S DiBiase
Journal:  J Neurosurg       Date:  2001-06       Impact factor: 5.115

3.  Cytokine expression in radiation-induced delayed cerebral injury.

Authors:  S A Kureshi; F M Hofman; J H Schneider; L S Chin; M L Apuzzo; D R Hinton
Journal:  Neurosurgery       Date:  1994-11       Impact factor: 4.654

4.  Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus.

Authors:  A P Lieberman; P M Pitha; H S Shin; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  A histological and flow cytometric study of dog brain endothelial cell injuries in delayed radiation necrosis.

Authors:  N Yamaguchi; T Yamashima; J Yamashita
Journal:  J Neurosurg       Date:  1991-04       Impact factor: 5.115

6.  Radiosurgery-induced microvascular alterations precede necrosis of the brain neuropil.

Authors:  T Kamiryo; M B Lopes; N F Kassell; L Steiner; K S Lee
Journal:  Neurosurgery       Date:  2001-08       Impact factor: 4.654

7.  Treatment of radiation-induced nervous system injury with heparin and warfarin.

Authors:  M J Glantz; P C Burger; A H Friedman; R A Radtke; E W Massey; S C Schold
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

8.  Hyperbaric oxygen therapy for radiation-induced brain injury in children.

Authors:  P J Chuba; P Aronin; K Bhambhani; M Eichenhorn; L Zamarano; P Cianci; M Muhlbauer; A T Porter; J Fontanesi
Journal:  Cancer       Date:  1997-11-15       Impact factor: 6.860

9.  Conservative treatment of delayed cerebral radiation necrosis.

Authors:  P J Shaw; D Bates
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-12       Impact factor: 10.154

10.  Cerebral radiation necrosis following treatment of extracranial malignancies.

Authors:  J P Glass; T L Hwang; M E Leavens; H I Libshitz
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

View more
  27 in total

Review 1.  New advances that enable identification of glioblastoma recurrence.

Authors:  Isaac Yang; Manish K Aghi
Journal:  Nat Rev Clin Oncol       Date:  2009-10-06       Impact factor: 66.675

2.  Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Teresa Popolizio; Simona Bonavita; Mario de Cristofaro; Renata Conforti; Adriana Cristofano; Claudio Colonnese; Ugo Salvolini; Gioacchino Tedeschi
Journal:  Radiol Med       Date:  2014-01-10       Impact factor: 3.469

3.  [Reduced radiation-induced brain necrosis in nasopharyngeal cancer patients with bevacizumab monotherapy].

Authors:  Cedric Oliver Carl; Marvin Henze
Journal:  Strahlenther Onkol       Date:  2019-03       Impact factor: 3.621

4.  An analysis of radiation necrosis of the central nervous system treated with bevacizumab.

Authors:  Karen Tye; Herbert H Engelhard; Konstantin V Slavin; M Kelly Nicholas; Steven J Chmura; Young Kwok; Dominic S Ho; Ralph R Weichselbaum; Matthew Koshy
Journal:  J Neurooncol       Date:  2014-02-07       Impact factor: 4.130

Review 5.  Delayed brain radiation necrosis: pathological review and new molecular targets for treatment.

Authors:  Motomasa Furuse; Naosuke Nonoguchi; Shinji Kawabata; Shin-Ichi Miyatake; Toshihiko Kuroiwa
Journal:  Med Mol Morphol       Date:  2015-12       Impact factor: 2.309

6.  The Effectiveness of Bevacizumab in Radionecrosis After Radiosurgery of a Single Brain Metastasis.

Authors:  Durim Delishaj; Stefano Ursino; Francesco Pasqualetti; Ilaria Pesaresi; Ilaria Desideri; Mirco Cosottini; Concetta Laliscia; Fabiola Paiar; Maria Grazia Fabrini
Journal:  Rare Tumors       Date:  2015-12-29

7.  Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.

Authors:  Shingo Yonezawa; Kazuhiro Miwa; Jun Shinoda; Yuichi Nomura; Yoshitaka Asano; Noriyuki Nakayama; Naoyuki Ohe; Hirohito Yano; Toru Iwama
Journal:  J Neurooncol       Date:  2014-05-01       Impact factor: 4.130

8.  Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease.

Authors:  Stefano Telera; Alessandra Fabi; Andrea Pace; Antonello Vidiri; Vincenzo Anelli; Carmine Maria Carapella; Laura Marucci; Francesco Crispo; Isabella Sperduti; Alfredo Pompili
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

9.  Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.

Authors:  Roy Torcuator; Richard Zuniga; Yedathore S Mohan; Jack Rock; Thomas Doyle; Joseph Anderson; Jorge Gutierrez; Samuel Ryu; Rajan Jain; Mark Rosenblum; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2009-02-03       Impact factor: 4.130

10.  Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.

Authors:  Dustin Boothe; Robert Young; Yoshiya Yamada; Alisa Prager; Timothy Chan; Kathryn Beal
Journal:  Neuro Oncol       Date:  2013-06-27       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.